New hemodialysis access system.

Blood Purif

GL Consult, LLC, Duxbury, MA, USA.

Published: July 2013

A new blood access system for hemodialysis (HD) addresses the major shortcomings of current accessing techniques and helps overcome patient adversity with available choices. The system uses new methods, devices and compositions comprising several novel elements: (1) totally implanted port, elementally simple in design, small and robust with improved safety features, (2) engineered transcutaneous tissue tract (TTT) to precisely guide a tubular conduit to engage the implanted port, (3) viscoelastic gel prophylaxis for internal passages and surface interfaces of the port and TTT, (4) the tool kit aligns the TTT with the port and initiates TTT formation at the time of port placement, (5) an integrated external bloodline circuit comprising the interface between the implanted port and HD machine which can be reused for several treatment sessions. The system provides bloodless, painless, and fail-safe connections with redundant sealing along the complete blood path. It is substantially more robust than current access options and more convenient to use. TTT construct is durable, permanently aligned and fixed to the port enabling non-compromised tissue integrity during access penetration. A bullet-pointed tubular assembly enters and passes through the TTT confining the tubular device to advance towards the port and entering it to engage a solid tactually sensed stop indicating the correct position. The system may be used within a few days of port placement. The access is unobtrusive and preserves patient self-image.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000345180DOI Listing

Publication Analysis

Top Keywords

implanted port
12
port
9
access system
8
port placement
8
ttt
6
system
5
hemodialysis access
4
system blood
4
access
4
blood access
4

Similar Publications

Totally implantable central venous catheters (CVCs) are widely used in the management of patients with malignant diseases. Conventionally, port implantations were carried out by general surgeons and vascular radiologists. In recent years, the medical staff of the Medical Oncology department at the Central University Hospital of Asturias (HUCA) has developed a simplified methodology for the routine implantation of these devices.

View Article and Find Full Text PDF

The single port robotic nipple sparing mastectomy (SPrNSM) was recently introduced. This approach is safe and has led to favorable outcomes in relation to cosmetic result, patient satisfaction, and breast sensation. The typical reconstruction with all robotic nipple sparing mastectomies is implant based; however, this is not always what a patient desires.

View Article and Find Full Text PDF

Jejunal Artery Aneurysm Exclusion With Immediate Vascular Reconstruction: A Case Report.

Port J Card Thorac Vasc Surg

January 2025

Angiology and Vascular Surgery, Unidade Local de Saúde de São João; Surgery and Physiology, Faculdade de Medicina da Universidade do Porto, Portugal.

A 44 year-old previously healthy woman presented a persistent epigastric pain. Computed tomography revealed a saccular aneurysm with a diameter of 25x20 mm in the first jejunal artery and also a stenosis in the celiac trunk associated with median arcuate ligament syndrome, turning the hepatic perfusion dependent of the gastroduodenal artery flow. Through a midline laparotomy, celiac axis was exposed, and median arcuate ligament released for median arcuate ligament syndrome treatment.

View Article and Find Full Text PDF

Otherwise, inoperable. The role of ECMO in thoracic surgery - focus on the mediastinum.

Port J Card Thorac Vasc Surg

January 2025

Thoracic surgeon, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

The use of extracorporeal membrane oxygenation (ECMO) in surgery is expanding as the medical community started adopting it, with good results, for procedures with high risk of respiratory and hemodynamic instability. This technique provided the possibility to reduce the number of patients previously considered inoperable because of these limitations. Thymic epithelial tumors (TETs) are rare neoplastic mediastinal lesions, with a reported incidence of 0.

View Article and Find Full Text PDF

Biodegradable polymeric microsphere formulations of full-length anti-VEGF antibody bevacizumab for sustained intraocular delivery.

Drug Deliv Transl Res

January 2025

Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.

Age-related macular degeneration (AMD) is one of the leading causes of central vision loss in the elderly population. Bevacizumab, a full-length humanized monoclonal anti-VEGF antibody, is commonly used off-label drug to treat AMD. However, the dosing regimen of bevacizumab and other anti-VEGF antibodies requires monthly intravitreal injections followed by regular intravitreal injections at 4-16-week intervals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!